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Abstract
Background: Neuronal tissue has limited potential to self-renew or repair after neurological diseases. Cellular
therapies using stem cells are promising approaches for the treatment of neurological diseases. However, the
clinical use of embryonic stem cells or foetal tissues is limited by ethical considerations and other scientific
problems. Thus, bone marrow mesenchymal stomal cells (BM-MSC) could represent an alternative source of stem
cells for cell replacement therapies. Indeed, many studies have demonstrated that MSC can give rise to neuronal
cells as well as many tissue-specific cell phenotypes.
Methods: BM-MSC were differentiated in neuron-like cells under specific induction (NPBM + cAMP + IBMX +
NGF + Insulin). By day ten, differentiated cells presented an expression profile of real neurons. Functionality of
these differentiated cells was evaluated by calcium influx through glutamate receptor AMPA3.
Results: Using microarray analysis, we compared gene expression profile of these different samples, before and
after neurogenic differentiation. Among the 1943 genes differentially expressed, genes down-regulated are
involved in osteogenesis, chondrogenesis, adipogenesis, myogenesis and extracellular matrix component (tuftelin,
AGC1, FADS3, tropomyosin, fibronectin, ECM2, HAPLN1, vimentin). Interestingly, genes implicated in
neurogenesis are increased. Most of them are involved in the synaptic transmission and long term potentialisation
as cortactin, CASK, SYNCRIP, SYNTL4 and STX1. Other genes are involved in neurite outgrowth, early neuronal
cell development, neuropeptide signaling/synthesis and neuronal receptor (FK506, ARHGAP6, CDKRAP2,
PMCH, GFPT2, GRIA3, MCT6, BDNF, PENK, amphiregulin, neurofilament 3, Epha4, synaptotagmin). Using real
time RT-PCR, we confirmed the expression of selected neuronal genes: NEGR1, GRIA3 (AMPA3), NEF3, PENK
and Epha4. Functionality of these neuron-like cells was demonstrated by Ca2+ influx through glutamate receptor
channel (AMPA3) in the presence of two agonist glutamate, AMPA or CNQX antagonist.
Conclusion: Our results demonstrate that BM-MSC have the potential to differentiate in neuronal cells with
specific gene expression and functional properties. BM-MSC are thus promising candidates for cell-based therapy
of neurodegenerative diseases
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Background
Neurodegenerative disorders, such as Parkinson's and
Alzheimer's disease, stroke, epilepsy or trauma are charac-
terized by a loss of neurons. Neural tissue has a limited
capacity of repair after injury and neural stem cells are
localized to a selected region. Different studies have pro-
posed the use of fetal neural stem cells or neural cells
derived from embryonic stem cells to treat brain injury
[1,2]. However, their use is limited by ethical considera-
tions and other scientific problems.
It has been demonstrated that mesenchymal stromal cells
(MSC) may play a role in neurogenesis or repair brain
injury [3-5]. Expanded MSC were injected in different
parts of the brain (striatum or spinal cord) in a mouse
model of Parkinson's disease, albino-rat or injured spinal
cord rat. From five days to 5 weeks post-injection the
migration of MSC and the expression of typical markers
for neurons or astrocytes were observed. MSC can also
promote the neuronal recovery [6]. Using co-cultures with
mesencephalic cells, hippocampal brain slice or cerebellar
granule neurons, some investigators have demonstrated
the differentiation of bone marrow-MSC (BM-MSC) into
cells expressing neuronal/glial proteins. These results sug-
gest that cell-cell contacts play an important role in neural
differentiation [7,8]. However, in these both cases (graft
and coculture) the fusion between MSC and neuron/glial
cells cannot be excluded.
In vitro the neural differentiation of MSC documented in
literature required 5 hours to 10 days to obtain cells with
morphologic and expression patterns similar to "real"
neurons [9,10]. However typical morphology observed
with long thin neuritis like neurons seems associated with
chemical cytotoxicity induced by the neurogenic medium.
In fact, the use of Dimethyl Sulfoxide (DMSO), Beta-Mer-
captoethanol (BME) or Butyl Hydroxyanisole (BHA) may
cause retraction of the cytoplasm due to a rapid disruption
of actin cytoskeleton [11,12]. On the other hand, the
expression of neuronal markers evaluated by immunola-
beling was not always increased and was not every time
confirmed by RT-PCR analysis or proteomic analysis [13].
As confirm by other group, we have previously demon-
strated that before any differentiation MSC can express
specific neural proteins [14,15]. Induced cells with Neuro-
nal Progenitor Basal Medium (NPBM medium) or Neuro-
basal added with a mix cytokines, demonstrate an
increased expression of Tyrosine Hydroxylase (TH), MAP-
2, NF, NeuN, GABA, nestin and GFAP [14,16].
Although specific protein expression has been evaluated,
little is known about the biological process, the molecular
functions and the gene modulation during MSC differen-
tiation process.
In this study, to confirm the differentiation of MSC to
neural phenotype and to demonstrate that this differenti-
ation is not an artifact, we performed microarray analysis
to establish the gene expression profile of MSC before and
after neurogenic differentiation. Among the 54000 probe
sets corresponding to 39500 genes, 1943 probe sets were
modulated with a fold change of 1,5. Quantitative real
time PCR was also performed to confirm microarray data.
In this study, several neurogenic genes were upregulated.
Our results provide the ability of MSC to differentiate into
neurons and to evoke a fast synaptic transmission. These
results were confirmed by rapid increase level of intracel-
lular Ca 2+ level after glutamate or AMPA stimuli.
Results and discussion
Characterization and differentiation capacity of BM-MSC
We have previously demonstrated that two passages were
required to isolate a homogeneous population of MSC
using the plastic adhesion method [17]. These cells dis-
played spindle-shape morphology and were identified by
their expression for CD73, CD105, CD90 but negative for
all hematopoietic markers (CD45, CD34, HLA-Dr).
Before neurogenic induction, cells were also evaluated for
their multilineage capacity. These cells can be induced to
differentiate into osteocytes, adipocytes and chondrocytes
lineage using specific culture media (Figure 1A,B).
After 2 passages, more than 72% of cells naturally express
Nestin. Nevertheless, MAP-2 and TH expression were
weaker, less than 5,4% and 12.5% respectively.
After 10 days under neurogenic induction, the expression
of nestin remains relatively stable, but we observed a dra-
matically increase of more mature neuronal proteins
MAP-2 and TH, with more than 50,1% and 63,1% of pos-
itive cells respectively (Figure 2A,B).
Microarray analysis
In the aim to confirm the neuronal differentiation of BM-
MSC and to determine if they can modify their gene
expression profile in response to the neurogenic medium,
we performed microarray analysis.
For this study, three different samples of BM-MSC were
investigated before and after neurogenic differentiation
with Affymetrix microarray analysis.
Of 1943 probes sets, a total of 913 upregulated genes and
1030 downregulated genes were significantly modulated
after differentiation with a fold change of 1,5.
The identified genes were classified into different groups:
neuronal channel/transport, synaptic differentiation/
transmission, neuronal development, mesodermal differ-BMC Genomics 2008, 9:166 http://www.biomedcentral.com/1471-2164/9/166
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Characterization and differentiation of BM-MSC Figure 1
Characterization and differentiation of BM-MSC. (A) Reprentative flow cytometric analysis of cultured mesenchymal 
stomal cells. Solid white represente the isotype control. (B) A. BM-MSC, displayed an homogeneous morphology of fibroblastic 
cells. Cells were stained with May Grunwald Giemsa staining (40×). Under specific induction BM-MSC were differentiated into 
(B) adipocytes (lipid vacuoles were colored by Oil Red O, ×40), (C) osteocytes (calcium deposits were revealed by Von Kossa 
method, ×40), (D) chondrocytes (cell pellet was sectioned and stained by toluidine blue, ×4), and (E) neuron-like cells derived 
from BM-MSC upon treatment with neurogenic medium (×40). Expression of nestin and MAP-2 after 10 days induction, 
detected by immunofluorescence (F and G, 100×).
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entiation, extra cellular matrix component, cytoskeleton
and cell cycle/proliferation, regarding their function and
the pathway which in they were implicated (Table 2) [see
additional file 1].
Recent studies demonstrated that treatment of MSC with
chemical agents including DMSO/BHA induced a neuro-
nal morphology causing by disruption of cytoskeleton, a
loss of cell-adherence but BM-MSC showed signs of death
[11,13,19]. In this study, we observed that genes implied
in proliferation (SPD35, CDC20, GPC4, CDC42) were
downregulated but no variation of gene expression
involved in cell apoptosis or death were observed
(DAPK3, PDCD2, APAF1, ACIN1). Concordant results
were recently described using a similar neurogenic
medium. They postulate the post-mitotic status of differ-
entiated cells resulting by down regulation of genes impli-
cated in the cell cycle [20].
Flow cytometric analysis of neurone like cells Figure 2
Flow cytometric analysis of neurone like cells. Expression of nestin, MAP-2 and TH neural proteins before and after 10 
day exposure with neurogenic medium. (A) Typical FACS analysis of neuronal markers expressed by MSC before (gray histo-
gram) and after (black histogram) differentiation. White histogram represents the isotype control. (B) Percentage of positive 
cells for nestin, MAP-2 and TH before (gray) and after (black) specific neurogenic induction. The mean (SEM) was obtained 
from three independent experiments.
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Comparing the gene expression profile of human MSC
with CD34 positive cells, Silva et al demonstrated that
some genes were exclusively or highly represented in MSC
(Collagen type I, Fibronectin, MYL9, Biglycan) [18]. We
observed that all of these genes are downregulated after
neurogenic differentiation. Moreover, the "Mesenchymal
stem cell protein DSC96" and the "Mesoderm specific
transcript (MEST), two specific genes of mesodermal line-
age have an important decrease of 5,8 and 15,2 fold
respectively after neurogenic differentiation. A decreased
expression of genes involved in osteogenesis, myogenesis
or lipid metabolism was also observed. Differentiated
cells were not able to mineralize the matrix due to the
important decreased of TUFT1, COL IV, V, XI, XII, OSF-2 and
the modification of the extracellular matrix component
after the differentiation (CSPG4, HAPLN1, ECM2, FN1).
MSC were first identified for their capacity of differentia-
tion into adipocytes or osteocytes two distinct mesoder-
mal cell lineages. It is well established that the decrease of
osteoblast differentiation is associated with increase adi-
pocyte formation. In fact osteoporosis due to the aging
correlated with an increased of adipocytes into the bone
marrow [19]. We did not observe an increased expression
of adipocyte associated genes in response to the downreg-
ulation of gene linked to osteogenesis. In contrast, genes
involved in adipogenesis are decreased (MGLL, FADS3,
LYPLAL1).
According to the downregulation of mesenchymal genes,
differentiated cells have an increased expression of typical
neural genes involved in the synaptic transmission, neur-
ite outgrowth, neurotransmitter signaling/receptors and
neuronal cell development. Our microarray analysis
revealed increased expression of synaptic protein mRNA
involved in the synaptic vesicle pathway, such as Synapto-
tagmin (SYT), Phospholipase D1 (PLD1) Syntaxin 1A
(STX1A), Brain derived neurotrophic factor (BDNF) and
FGF7, favoring the presynaptic vesicle clustering (Figure
3).
Other genes upregulated after neurogenic induction were
involved in (1) synaptic transmission/long term poten-
tialisation: Ca2+/Calmodulin (CaM)-dependent kinases
(CASK), Promelanin concentrating hormone (PMCH),
The synatptic transmission gene expressed Figure 3
The synatptic transmission gene expressed. Schematic representation of localization and role of genes increased after 
neurogenic induction and involved in the synaptic transmission.
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Choline Transporter (CTL1), Proenkephalin (PENK), (2)
neurite outgrowth and neurogenesis: Neuronal Growth
Regulator 1 (NRG1), Brain abundant membrane attached
signal protein 1 (BASP1), Amphiregulin (AREG), Eph
receptor A4 (EPHA4), neurofilament 3 (NEF3). (3) neu-
rotransmitter receptor/transporters and channels:
Glutamate receptor (AMPA3),, Na+/Sialic cotransporter
(LAT2), Potassium voltage gated channel, subfamily G,
Member 1 (KCNG1), Gaba (A) receptor associated pro-
tein-like 1 (GABARAPL1).
Quantitative RT-PCR analysis
To confirm the gene expression profile revealed by micro-
array analysis, quantitative RT-PCR was carried out. Rep-
resentative genes involved into neural development/
differentiation (EphA4, AMPA3, NEGR1, NEF3, PENK)
and in mesodermal cell lineage (HAPLN1, CSPG4,
CALD1, VIM, DSC96, MEST, TUFT1) were selected from
our microarray analysis. We evaluated the mRNA gene
expression between undifferentiated/differentiated cells
in comparison with a housekeeping gene (β-actin). As
show in figure 4, using quantitative real-time PCR, we
confirmed the increased expression of EphA4, AMPA3,
NEGR1, NEF3 and PENK by differentiated MSC ten days
after neurogenic induction. In contrast, genes expressed
naturally by BM-MSC were downregulated after neuro-
genic induction (HAPLN1, CSPG4, CALD1, VIM, DSC96,
MEST, TUFT1).
Calcium Influx
Increased mRNA expression of a high number of neural
synaptic genes by microarray or real-time PCR by differen-
tiated BM-MSC is not sufficient to demonstrate the differ-
entiation status. It will be important that neural-like cells
obtained after in vitro differentiation of BM-MSC were
functional and able to have synaptic transmission poten-
tial.
Excitory synaptic currents are mediated by different types
of glutamate receptor channels including AMPA3, also
named GRIA3 or GluR3. Calcium influx plays an impor-
tant role in the synaptic transmission. In this way, we
investigated the Calcium influx though GRIA3 receptor.
Ca2+ influx was measured using Fluo-4 NW assay kit in the
presence of glutamate (100 μM), or AMPA (40 μM) both
agonist of GRIA3 and CNQX (10 μM), antagonist of
GRIA3.
Treatment of GRIA3 with AMPA or Glutamate, demon-
strated an important increased of Ca2+ influx in compari-
son with the addition of CNQX, the specific antagonist of
GRIA3 (Figure 5) were demonstrated. The presence of
Quantitative real-time PCR analysis Figure 4
Quantitative real-time PCR analysis. Quantitative real-time PCR analysis using β-actin as a housekeeping gene and cali-
brated with the PANOMICS: Human brain total RNA (invitrogen, Brussels, Belgium). Results are expressed in fold change sig-
nal between differentiated and non-differentiated BM-MSC after the neurogenic induction. Selected neuronal genes were 
NEGR1, EphA4, NEF3, GRIA3 (AMPA), PENK (Grey column). Selected mesenchymal genes were HAPLN1, VIM, CSPG4, 
CALD1, DSC96, MEST, TUFT1 (black column).
-10
-5
0
5
10
15
20
25
30
Actin NEGR1 Epha4 NEF3 PENK GRIA HAPLN1 VIM CSPG4 CALD1 DSC96 MEST TUFT1
F
o
l
d
 
c
h
a
n
g
e
 
s
i
g
n
a
l
 
(
d
i
f
f
e
r
e
n
t
i
a
t
e
d
/
u
n
d
i
f
f
e
r
e
n
t
i
a
t
e
d
 
c
e
l
l
)BMC Genomics 2008, 9:166 http://www.biomedcentral.com/1471-2164/9/166
Page 7 of 11
(page number not for citation purposes)
CNQX completely abolished the entry of Ca2+ through
the AMPA3 receptor.
All measures were tested in a calcium buffer containing
0,15 μM of free Ca2+. These results suggest both the fully
differentiation of BM-MSC into phenotypical neurons but
also their functionality in our neurogenic conditions.
Discussion
Accordingly to easy accessibility within the bone marrow
and the important potential of differentiation, BM-MSC
represent interesting candidates for gene therapy, tissue
engineering and a wide range of regenerative medicine
applications [23]. Recent observations demonstrated the
capacity of BM-MSC to migrate and to differentiate into
various damaged tissues. However, molecular mecha-
nisms implied in the differentiation process remain
largely unknown. A great number of studies have evalu-
ated the neuronal differentiation potential of BM-MSC in
vitro, using different protocols of induction. DMSO, RA,
BHA, IBMX or BME were used as inducible agents, and
morphologic changes of BM-MSC were rapidly observed
(within few hours) with variable percentage of cell
expressing neuronal markers (neuron-specific enolase,
tau, neuronal nuclear antigen, [9,24,25]. Recently, Neu-
huber et al, reevaluated the in vitro differentiation proto-
cols and demonstrated the chemical toxicity of these
agents on the cytoskeleton of MSC. These chemical agents
induced rapid disruption of actin with an aberrant expres-
sion of neuronal proteins arguing against neurogeneic dif-
ferentiation [11]. Using microarray analysis genes
modulated by DMSO/BHA induction were different from
those observed during neurogenesis in neural tissue.
Moreover, differentiation process required cascades of
transcriptional events that could not be able to realize
within a few hours [13,26]. They demonstrated that expo-
sition to DMSO/BHA resulted to a reversible lost cell con-
tact with the substratum leading to the detachment of BM-
MSC. In these conditions, the morphological shape seems
associated to a decrease of cell anchorage and not to a real
neuritis outgrowth. Moreover, a high percentage of apop-
totic cells were present after induction with DMSO/BHA.
However, dermal fibroblasts also responded to chemical
induction by forming long thin process and expressing
some neuron and glial markers. The rapidity of neuron-
Intracellular Calcium influx Figure 5
Intracellular Calcium influx. Representative variation of intracellular Calcium influx in differentiated MSC treated with 
AMPA (40 μM, ---×---), glutamate (100 μM,  ) or CNQX (10 μM,  ). Results are expressed as fluorescence 
intensity at 4 second-intervals using the Fluo-4 NW tracer. Agonists (AMPA or Glutamate) and antagonist CNQX were com-
pared with spontaneous level of calcium influx in presence of Ca2+ alone ( ).
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like differentiation argues against physiological cell differ-
entiation [27].
We did not observe morphological changes using our
neurogenic induction medium on fibroblastic lineage
(MRC5). In comparison with BM-MSC, no expression of
neuronal markers was observed during the treatment of
MRC5 cells (data not shown). This observation demon-
strated the absence of cytotoxic effect on the cytoskeleton
in our conditions of neurogenic induction.
The presence or absence of specific antigen expression can
not prove the differentiation of MSC. In fact, undifferenti-
ated BM-MSC can express a large number of antigens from
other tissues in which they reside [14,28-30].
During the differentiation process and contrasting to pre-
vious studies, we did not observed morphological
changes within a few hours using our neurogenic induc-
tion medium [9,23,31]. An average of four days was
required to display cells with neuron-like characteristics,
and ten days to obtain more than 70–80% of differenti-
ated BM-MSC. Removing the neurogenic medium the dif-
ferentiated BM-MSC did not spontaneously return to their
fibroblastic morphology within the 48 hours. Due to sta-
bility of the differentiated state, we decided to analyze the
profile of gene expression during the differentiating proc-
ess.
Using the microarray technology a great number of genes
can be compared in undifferentiated and differentiated
BM-MSC and could explain the mechanism of neuronal
differentiation. The protein expression profiles of MSC
and osteoblasts revealed an important decreased expres-
sion of calmodulin, calponin, calpain, caldesmon and
many others, after differentiation of MSC [32]. During the
neuronal differentiation of BM-MSC, we observed similar
decrease of mRNA levels corresponding to proteins
involved in matrix mineralization. Interestingly, using our
neuronal induction protocol, we also observed that genes
implicated in neurogenesis are increased and specially
those in relation with the synaptic transmission (AMPA,
synaptotagmin, CASK, Syntaxin 1A, SNCAIP, MCT2).
Indeed, each gene taken separately, we cannot conclude
that BM-MSC can differentiate into neurons. But assem-
bling all upregulated/downregulated genes, the differenti-
ation potential of MSC into neural cell lineage seems
confirmed. Analysing these results, we observed that
genes implicated in neuronal differentiation of neuronal
precursors, including SOCS2, sFRP1, amphiregulin, neu-
ronal growth regulator 1 and EphA4, were also upregu-
lated after neurogenic differentiation of BM-MSC [33-35].
More interestingly, in comparison of genes associated dur-
ing neural differentiation process of human embryonic
stem cells or human brain with our results, we also found
increased expression of PENK, STK4, IGFBP4, Slc17a6,
Slc6A1, Nurr1, Nrp2, Moxd1, Shh and Neurod2 [36,37].
Taken together with TH expression demonstrated by flow
cytometry, we speculate that our neurogenic medium can
promote the neuronal-dopaminergic differentiation path-
way. Nevertheless, persistent high expression of nestin
after 10 days of differentiation suggest the presence of
mixed cell population at different stages of maturation or
differentiation. However, the important decreased of
genes involved in the proliferation suggests the post-
mitotic state of these differentiated cells.
A recent study evaluating genes implied in neuronal dif-
ferentiation of MSC, evidenced by Oligo GEarrays spe-
cially used to neural study (neurotransmitter receptors
and regulators, neurogenesis and neural stem cells), dem-
onstrated a large up-regulation of genes. More interest-
ingly, as observed in our study, they also demonstrated
the arrested growth of treated cells by important decrease
of cell-cycle specific genes without increase of proapop-
totic genes. They demonstrated also their functionality by
the production of neurotransmitters and synaptic vesicle
release of dopamine in response to a depolarizing stimu-
lus [20].
Using similar neurogenic medium (NPMM or Neuroba-
sal), MSC expressed dopaminergic specific genes (En1,
En2, LMx1a, Wnt1, Ptx3, and Nuur1 and were positive to
GFAP, MAP-2 and NSE but continued to express the neu-
ral stem cell marker nestin. Differentiated cells demon-
strated the presence of two delayed rectifier K+ currents
and one Ca2+-depend K+ regulatory currents contributing
to the degree of excitability of neurons in human and pro-
duced neurotransmitter substance P with functional syn-
apses. Nevertheless, treated cells were not always able to
exhibit spontaneous and evoke action potential, suggest-
ing that cells are not fully differentiated [38]. They con-
firmed our results by the fact that in vitro differentiation
protocol could be sufficient to obtain post-mitotic neu-
rons able to communicate with other cells by neurotrans-
mitter way. Thus, it seems possible that BM-MSC may be
primed in vitro towards mature dopamine secreting cells
[20,39,40].
In our present study, microarray analysis and real-time
PCR, realized both on BM-MSC and neuron-like cells,
have demonstrated an increased expression of ionotropic
glutamate receptor AMPA3, also called GRIA3 or GluR3.
Functionality of this receptor was proved by measuring
calcium influx in addition of specific agonists (AMPA or
glutamate) or antagonist (CNQX). AMPA evoked an
increased calcium influx in comparison with Calcium
alone or in presence of antagonist (CNQX).BMC Genomics 2008, 9:166 http://www.biomedcentral.com/1471-2164/9/166
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These recent finding cannot exclude the possibility that
complete differentiation or maturation of differentiated
cells require more specific factors. In fact, the microenvi-
ronment of each tissue plays an important role in the
growth and differentiation of stem cells including local
secreted factors, cell-cell interactions and extracellular
matrix. It has been demonstrated that co-cultures with
neurons or astrocytes are required for the functionality of
BM-MSC derived neural cells [8,41,42]. After short co-cul-
ture period with neuro/glial cells, the neuro-mesenchy-
mal cells were able to conduct single-action potentials as
real neurons.
Conclusion
In conclusion, the neurogenic induction protocol used in
this study has no cytotoxic effect on MSC and promotes
their differentiation into functional dopaminergic neu-
rons as demonstrated by flow cytometry, RT-PCR, micro-
array and calcium influx. This medium will be important
to guide their differentiation for future clinical uses in
neurodegenerative diseases.
Methods
BM-MSC cultures
BM-MSC were obtained from healthy volunteer donors (n
= 6) by sternal aspirates after informed consent. MSC were
isolated using the classical adhesion method. Briefly, we
seeded mononuclear cells (0,5.104 cells/cm2) in DMEM
medium (Lonza, Verviers, Belgium) supplemented with
15% FBS (Sigma, St Louis, Missouri USA), 2 mM L-
glutamine (Gibco BRL, Grand Island, NY) and 0,5% anti-
biotic-antimycotic solution (Gibco BRL). Cultures were
replaced twice a week until 70–80% confluent. BM-MSC
were characterized by flow cytometry and their differenti-
ation potential was investigated. Adipogenic, osteogenic
and chondrogenic differentiation was performed as previ-
ously described [17]. Lipid vacuoles, calcium deposits and
chondrogenic matrix were observed and identified by Oil
Red O (Sigma), Von Kossa, and toluidin blue staining
methods respectively.
Antibodies and cytokines
The MSC phenotype was determined using the following
antibodies: CD34-PE/CY5 (ImTec Diagnostics NV),
CD45-CY5 (BD Pharmingen, Erembodegem, Belgium),
CD73-PE (BD), CD90-FITC (RD System, Abingdon,
United Kingdom), CD105-FITC (RD System), CD166-
FITC (AbD Serotec, Cergy St Christophe, France) and
HLA-Dr-CY5 (Immunotech, Marseille, France). Cells were
incubated during 30 minutes at room temperature. Data
were acquired on a Coulter EPICS-XL (Coulter, Miami, FL,
USA).
Neurogenic differentiation
After 2 passages, when cells are positive for mesenchymal
markers (CD105, CD90, CD73, CD166) and negative for
hematopoietic/endothelial markers (HLA-Dr, CD34,
CD45), we differentiated them with the neurogenic
medium as previously described [14]. Briefly, 1,5.103
cells/cm2 were cultured in NPBM medium (Cambrex).
This medium was supplemented with 5 μM cAMP
(Sigma), 5 μM IBMX (Sigma), 25 ng/mL NGF (Sigma) and
2,5 μg/mL insuline (Sigma). Half differentiation medium
was changed twice a week during ten days. Three undiffer-
entiated/differentiated cell couples were used for the
microarray study and three new couples were added for
real-time PCR analysis.
Flow cytometric analysis of differentiated cells
The effect of our neurogenic medium on neuronal marker
expression was evaluated by flow cytometric analysis
using the following antibodies: nestin (Chemicon Inter-
national, Temecula, CA USA), MAP-2 (Sigma) and TH
(Sigma). Since these proteins were intracytoplasmic, cells
were fixed and permeabilized with an acetone/methanol
(1/1 solution) for 5 min at -20°C.
Microarray analysis
Total RNA from both differentiated and undifferentiated
MSC was extracted and purified with RNeasy purification
Kit (Qiagen, Valencia, CA, USA). Then, double-stranded
cDNA was synthesized using the One-Cycle cDNA synthe-
sis Kit (Affymetrix, Santa Clara, CA, USA). The cRNA, per-
formed by in vitro transcription, was biotinylated using
the IVT Labeling Kit according to the manufacturer's rec-
ommendations (Affymetrix) and hybrided to the probe
HG-U133 Plus 2.0 GeneChips which included 54675
cDNA sequences (Affymetrix). Genes called "absent" for
six or five out of six MSC (undifferentiated/differenti-
ated), defined by the Affymetric algorithm, were excluded.
Data were normalized with RMA method, with processes
a group of CEL files simultaneously [18]. The signal inten-
sity with a fold change of 1,5 (decrease or increase)and
common to each group of differentiated/undifferentiated
MSC were analyzed using the parametric t-test with a p-
value <0,05 and a fold discovery rate (FDR) of q<7%. We
identified 1943 genes in which 913 were upregulated and
1030 downregulated after neurogenic differentiation.
Quantitative Real-Time PCR analysis
Total RNA was extracted from differentiated and undiffer-
entiated MSC using Tripure Isolation Reagent (Roche
Applied Science, Mannheim, Germany). We performed
the reverse transcription with 1 μg RNA using the M-MLV
reverse transcriptase (Invitrogen life Technologies, Merel-
beek, Belgium) in a final volume of 20 μL containing 1 μg
RNA, 4 μL first strand buffer, 10-2 M DTT, 2 mM of each
dNTP, 12 U Rnase inhibitor and 100 U M-MLV reverseBMC Genomics 2008, 9:166 http://www.biomedcentral.com/1471-2164/9/166
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transcriptase. The reverse transcription was performed for
45 minutes at 42°C and followed by an enzyme-inactiva-
tion step. Then, transcripts encoding neuro-regulatory or
mesenchymal proteins (Table 1) [see additional file 1]
were quantified using 20 ng of cDNA in a quantitative
PCR with 2X SYBR Green PCR Master Mix (Applied Bio-
systems, Lennik, Belgium) added with 0,32 μM of each
forward and reverse primers. These primers were designed
with the Primer Express 2.0 software (Applied Biosys-
tems). To compensate variation of input RNA amount or
efficiency of reverse transcription enzyme, a housekeeping
gene was used to quantify and normalize the results (β-
actin). The reaction was carried out using the ABI Prism
7900 HT (Applied Biosystems). In all cases, dissociation
curves were made and confirmed the specificity of PCR
reactions. The amplified fragments were isolated
(Qiaquick Gel Extraction kit, Qiagen) and diluted to gen-
erate the standard curves for reproducibility and efficiency
of the reaction. The comparative ct method was applied
for data analysis.
Ca2+ influx measurement
Intracellular fluorescent Ca2+ was measured with Fluo-4
indicator (Molecular Probes, Belgium) in neuron-like
cells cultured in 96 well black microplates (Poly D-lysin
coated, Greiner Bio-One, Germany). Cells were seeded at
3000 cells/well during 48 hours and then differentiated
during 10 days with the neurogenic medium. Briefly,
Fluo-4 solution (2,5 mM) was prepared according the
manufacturer's recommendations and put on cell culture.
Plates were first incubated at 37°C for 30 minutes and
then at room temperature for an additional time of 30
minutes. Then, we added CNQX (10 μM, 6-cyano-
7nitroquinoxaline-2,3-dione, Sigma), (±) AMPA hydro-
bromide (40 μM,  α-Amino-3-hudroxy-5-methylisoxa-
zole-4-propionic acid, Sigma) or Glutamate (100 μM,
Sigma) in a calcium buffer solution containing 5 mM
CaEGTA, 5 mM EGTA, 100 mM KCl and 30 mM MOPS
with free 0.15 μM Ca2+ (Molecular Probes) and plates
were measured immediately.
The Fluo-4 indicator was excited at 488 nm and analyzed
at 518 nm using the Fluostar optima (BMG Labtech, Neth-
erlands). Measures were acquired every 4 second interval
and expressed as Fluorescence Intensity.
Additional material
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